Treatment of metastatic melanoma-derived cell lines with histone deacetylase inhibitor and demethylating agents demonstrated that this increase in CCR7 expression is associated with the enhanced migratory responses to CCL21 stimulation (54). Here, CCR7 is linked to metastatic melanoma.